OKYO Pharma Limited (OKYO)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | — |
|
| Statements | ||
| Consolidated Balance Sheets | — |
|
| Consolidated Statements of Operations and Comprehensive Loss | — |
|
| Consolidated Statements of Shareholders' Equity | — |
|
| Consolidated Statements of Cash Flows | — |
|
| Notes | ||
| Accounting Policies | — |
|
| Auditors Renumeration | — |
|
| Auditorâs Remuneration | — |
|
| Basic and Diluted Loss Per Share | — |
|
| Capital and Reserves | — |
|
| Cash and Cash Equivalents | — |
|
| Cash and Cash Equivalents and Short Term Investments | — |
|
| Commitments and Contingencies | — |
|
| Convertible Loan Instruments | — |
|
| Critical Accounting Judgements and Key Sources of Estimation Uncertainty | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Employees Including Officers, Executive and Non-executive Directors | — |
|
| Finance Income and Costs | — |
|
| Financial Instruments | — |
|
| Insider Trading Policies and Procedures | — |
|
| Leases | — |
|
| Operating Expenses | — |
|
| Post Balance Sheet Events | — |
|
| Prepaid Expenses and Other Receivables | — |
|
| Property, Plant and Equipment | — |
|
| Related Party Transactions | — |
|
| Remuneration of Key Management Personnel | — |
|
| Reporting Entity | — |
|
| Segmental Reporting | — |
|
| Share Options and Warrants | — |
|
| Taxation | — |
|
| Trade and Other Payables | — |
|